GenSight’s RESCUE Trial Shows Positive Results for Rare Eye Disease Clinical Data, Clinical Trials, European Medicines Agency, FDA, Leber Hereditary Optic Neuropathy (LHON), R&D, Vision Loss Paris-based GenSight Biologics reported the first group of data from Week 96 of the company’s RESCUE Phase III clinical trial. Read more September 24, 2019/by BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png BioSpace2019-09-24 12:41:432019-09-24 13:18:05GenSight’s RESCUE Trial Shows Positive Results for Rare Eye Disease
